secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-09-10T23:24:47+00:00
Accession:  0001628280-26-061445
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen shareholders elect board, back say-on-pay and KPMG at annual meeting
-----------------------------------------------------------------------------

- All four director nominees elected: Saxe, Cunningham, Williamson, Singh; Cunningham and Singh saw narrower support (4.66M/3.83M and 4.97M/3.53M).
- Say-on-pay advisory vote approved: 6,625,045 for, 1,142,430 against, 729,413 abstentions.
- KPMG LLP ratification approved as FY2027 auditor: 22,495,649 for, 680,897 against, 685,683 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/0001628280-26-061445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026061445/vtgn-20260910.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-061445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer